Trial Profile
HIV infection and breastfeeding: Interventions for maternal and infant health
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine (Primary) ; Lopinavir/ritonavir (Primary) ; Nevirapine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms BAN
- 12 Dec 2018 Results published in the JAIDS
- 01 Jan 2012 An article regarding the antiretroviral choice by women on this study, and the response to the DSMB decision to stop the control arm has been published in Contemporary Clinical Trials.
- 17 Jun 2010 Results have been published in the New England Journal of Medicine (NEJM).